ZYME
Zymeworks Inc. Common Stock
NASDAQ: ZYME · HEALTHCARE · BIOTECHNOLOGY
$27.83
-0.39% today
Updated 2026-04-29
Market cap
$2.07B
P/E ratio
—
P/S ratio
19.51x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$11 – $30
Volume
0.7M
Zymeworks Inc. Common Stock (ZYME) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-76.60%
Operating margin
-1,756.00%
ROE
-26.70%
ROA
-14.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $1.67M | $-12.94M | -527.13% | -763.35% | -774.97% |
| 2015 | $9.66M | $-19.17M | -152.62% | -206.63% | -198.45% |
| 2016 | $11.01M | $-33.81M | -222.93% | -343.94% | -307.10% |
| 2017 | $51.76M | $-10.41M | 20.51% | -17.38% | -20.10% |
| 2018 | $53.02M | $-36.56M | 100.00% | -62.48% | -68.95% |
| 2019 | $29.54M | $-145.44M | -296.34% | -512.12% | -492.27% |
| 2020 | $38.95M | $-180.55M | 100.00% | -481.29% | -463.54% |
| 2021 | $26.68M | $-211.84M | 100.00% | -808.22% | -794.01% |
| 2022 | $412.48M | $124.34M | 100.00% | 31.64% | 30.14% |
| 2023 | $76.01M | $-118.67M | -88.11% | -181.62% | -156.13% |
| 2024 | $76.30M | $-122.69M | 100.00% | -179.69% | -160.80% |
| 2025 | $105.97M | $-81.13M | 89.81% | -87.34% | -76.56% |